Sysmex Corp. (6869)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Sysmex Corp. (6869)
Go deeper and ask any question about 6869
Company Performance
Current Price
as of Sep 17, 2024$20.07
P/E Ratio
33.88
Market Cap
$12.4B
Description
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Metrics
Overview
- HQKobe, HY
- SectorHealth Technology
- IndustryMedical Specialties
- Ticker6869
- Price$20.065583+1.93%
Trading Information
- Market Cap$12.40B
- Float72.93%
- Average Daily Volume (1m)1,377,662
- Average Daily Volume (3m)1,454,000
- EPS$83.25
Company
- Revenue$478.10B
- Rev Growth (1yr)17.40%
- Net Income$11.03B
- Gross Margin53.63%
- EBITDA Margin23.63%
- EBITDA$26.45B
- EV$1.60T
- EV/Revenue3.34
- P/E33.88
- P/S3.68